QUOTE AND NEWS
Market Intelligence Center  Dec 17  Comment 
The patented options-trade picking algorithms used by MarketIntelligenceCenter.com found a trading opportunity with Perrigo (PRGO) that should provide a 3.40% return in just 65 days. Sell one Feb. '15 call at the $150.00 level for each 100 shares...
Forbes  Nov 20  Comment 
In afternoon trading on Thursday, Healthcare stocks are the worst performing sector, showing a 0.2% loss. Within that group, Actavis (NYSE: ACT) and Perrigo Company (NYSE: PRGO) are two large stocks that are lagging, showing a loss of 2.9% and...
Wall Street Journal  Nov 20  Comment 
Perrigo plans to sell $900 million in stock to fund its acquisition of Omega Pharma Invest, which it agreed to buy earlier this month for $4.5 billion.
Market Intelligence Center  Nov 13  Comment 
Perrigo (PRGO) traded between $153.85 and $155.04 before closing at $154.87 Wednesday and presents some attractive trading opportunities today according to MarketIntelligenceCenter.com's patented algorithms. The computer program that picks trades...
StreetInsider.com  Nov 6  Comment 
Market wrap for November 6th End of the Day: S&P 500 up 7.6 to 2,031.21; Dow Jones up 69.9 to 17,554.47; Nasdaq up 17.8 to 4,638.47 * In the week ending November 1, the advance figure for seasonally adjusted initial claims was 278,000, a...
StreetInsider.com  Nov 6  Comment 
* Cott Corp. (NYSE: COT) announced that it has entered into a definitive merger agreement to acquire DSS Group, Inc., parent company to DS Services of America, Inc. ("DSS"), a leading water and coffee direct-to-consumer services provider in the...
FiercePharma  Nov 6  Comment 
Perennial dealmaker Perrigo signed on the dotted line for Belgium's Omega Pharma, elbowing past rival bidders to expand its footprint in the global OTC market.  
Wall Street Journal  Nov 6  Comment 
Perrigo agreed to buy Belgium-based Omega Pharma in a deal valued at $4.5 billion as part of a bid to expand its portfolio of over-the-counter drugs and broaden its presence throughout Europe.




 

Perrigo Company is a global health-care supplier and the world's largest manufacturer of over-the-counter pharmaceuticals for the store brand market. The company develops, distributes, and manufactures over-the-counter and prescription pharmaceuticals, nutritional products, active pharmaceutical ingredients, and consumer products.

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki